▶ 調査レポート

世界の前臨床用流体市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Fluidics for Preclinical Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の前臨床用流体市場規模・現状・予測(2021年-2027年) / Global Fluidics for Preclinical Market Size, Status and Forecast 2021-2027 / QFJ1-5168資料のイメージです。• レポートコード:QFJ1-5168
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、95ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、前臨床用流体の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(ソフトウェア用付属品、精密シリンジポンプ)、用途別市場規模(診療所、研究所)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・前臨床用流体の市場動向
・企業の競争状況、市場シェア
・前臨床用流体の種類別市場規模と予測2016-2027(ソフトウェア用付属品、精密シリンジポンプ)
・前臨床用流体の用途別市場規模と予測2016-2027(診療所、研究所)
・前臨床用流体の北米市場規模2016-2027(アメリカ、カナダ)
・前臨床用流体の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・前臨床用流体のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・前臨床用流体の中南米市場規模2016-2027(メキシコ、ブラジル)
・前臨床用流体の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(AMETEK Inc、Blacktrace Holdings Ltd、Fluigent SA、Halma Plc、Harvard Bioscience Inc、IDEX Corp、IMI Plc、M Dialysis AB、Thermo Fisher Scientific Inc)
・結論

Fluid mechanics techniques and products used in clinical medicine.

Market Analysis and Insights: Global Fluidics for Preclinical Market
The global Fluidics for Preclinical market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Fluidics for Preclinical market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Fluidics for Preclinical market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Fluidics for Preclinical market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Fluidics for Preclinical market.

Global Fluidics for Preclinical Scope and Market Size
Fluidics for Preclinical market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Fluidics for Preclinical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Software and Accessories
Precision Syringe Pumps

Segment by Application
Clinica
Research

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AMETEK Inc
Blacktrace Holdings Ltd
Fluigent SA
Halma Plc
Harvard Bioscience Inc
IDEX Corp
IMI Plc
M Dialysis AB
Thermo Fisher Scientific Inc

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fluidics for Preclinical Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Software and Accessories
1.2.3 Precision Syringe Pumps
1.3 Market by Application
1.3.1 Global Fluidics for Preclinical Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinica
1.3.3 Research
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Fluidics for Preclinical Market Perspective (2016-2027)
2.2 Fluidics for Preclinical Growth Trends by Regions
2.2.1 Fluidics for Preclinical Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Fluidics for Preclinical Historic Market Share by Regions (2016-2021)
2.2.3 Fluidics for Preclinical Forecasted Market Size by Regions (2022-2027)
2.3 Fluidics for Preclinical Industry Dynamic
2.3.1 Fluidics for Preclinical Market Trends
2.3.2 Fluidics for Preclinical Market Drivers
2.3.3 Fluidics for Preclinical Market Challenges
2.3.4 Fluidics for Preclinical Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Fluidics for Preclinical Players by Revenue
3.1.1 Global Top Fluidics for Preclinical Players by Revenue (2016-2021)
3.1.2 Global Fluidics for Preclinical Revenue Market Share by Players (2016-2021)
3.2 Global Fluidics for Preclinical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Fluidics for Preclinical Revenue
3.4 Global Fluidics for Preclinical Market Concentration Ratio
3.4.1 Global Fluidics for Preclinical Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fluidics for Preclinical Revenue in 2020
3.5 Fluidics for Preclinical Key Players Head office and Area Served
3.6 Key Players Fluidics for Preclinical Product Solution and Service
3.7 Date of Enter into Fluidics for Preclinical Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Fluidics for Preclinical Breakdown Data by Type
4.1 Global Fluidics for Preclinical Historic Market Size by Type (2016-2021)
4.2 Global Fluidics for Preclinical Forecasted Market Size by Type (2022-2027)

5 Fluidics for Preclinical Breakdown Data by Application
5.1 Global Fluidics for Preclinical Historic Market Size by Application (2016-2021)
5.2 Global Fluidics for Preclinical Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Fluidics for Preclinical Market Size (2016-2027)
6.2 North America Fluidics for Preclinical Market Size by Type
6.2.1 North America Fluidics for Preclinical Market Size by Type (2016-2021)
6.2.2 North America Fluidics for Preclinical Market Size by Type (2022-2027)
6.2.3 North America Fluidics for Preclinical Market Size by Type (2016-2027)
6.3 North America Fluidics for Preclinical Market Size by Application
6.3.1 North America Fluidics for Preclinical Market Size by Application (2016-2021)
6.3.2 North America Fluidics for Preclinical Market Size by Application (2022-2027)
6.3.3 North America Fluidics for Preclinical Market Size by Application (2016-2027)
6.4 North America Fluidics for Preclinical Market Size by Country
6.4.1 North America Fluidics for Preclinical Market Size by Country (2016-2021)
6.4.2 North America Fluidics for Preclinical Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Fluidics for Preclinical Market Size (2016-2027)
7.2 Europe Fluidics for Preclinical Market Size by Type
7.2.1 Europe Fluidics for Preclinical Market Size by Type (2016-2021)
7.2.2 Europe Fluidics for Preclinical Market Size by Type (2022-2027)
7.2.3 Europe Fluidics for Preclinical Market Size by Type (2016-2027)
7.3 Europe Fluidics for Preclinical Market Size by Application
7.3.1 Europe Fluidics for Preclinical Market Size by Application (2016-2021)
7.3.2 Europe Fluidics for Preclinical Market Size by Application (2022-2027)
7.3.3 Europe Fluidics for Preclinical Market Size by Application (2016-2027)
7.4 Europe Fluidics for Preclinical Market Size by Country
7.4.1 Europe Fluidics for Preclinical Market Size by Country (2016-2021)
7.4.2 Europe Fluidics for Preclinical Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Fluidics for Preclinical Market Size (2016-2027)
8.2 Asia-Pacific Fluidics for Preclinical Market Size by Type
8.2.1 Asia-Pacific Fluidics for Preclinical Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Fluidics for Preclinical Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Fluidics for Preclinical Market Size by Type (2016-2027)
8.3 Asia-Pacific Fluidics for Preclinical Market Size by Application
8.3.1 Asia-Pacific Fluidics for Preclinical Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Fluidics for Preclinical Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Fluidics for Preclinical Market Size by Application (2016-2027)
8.4 Asia-Pacific Fluidics for Preclinical Market Size by Region
8.4.1 Asia-Pacific Fluidics for Preclinical Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Fluidics for Preclinical Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Fluidics for Preclinical Market Size (2016-2027)
9.2 Latin America Fluidics for Preclinical Market Size by Type
9.2.1 Latin America Fluidics for Preclinical Market Size by Type (2016-2021)
9.2.2 Latin America Fluidics for Preclinical Market Size by Type (2022-2027)
9.2.3 Latin America Fluidics for Preclinical Market Size by Type (2016-2027)
9.3 Latin America Fluidics for Preclinical Market Size by Application
9.3.1 Latin America Fluidics for Preclinical Market Size by Application (2016-2021)
9.3.2 Latin America Fluidics for Preclinical Market Size by Application (2022-2027)
9.3.3 Latin America Fluidics for Preclinical Market Size by Application (2016-2027)
9.4 Latin America Fluidics for Preclinical Market Size by Country
9.4.1 Latin America Fluidics for Preclinical Market Size by Country (2016-2021)
9.4.2 Latin America Fluidics for Preclinical Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Fluidics for Preclinical Market Size (2016-2027)
10.2 Middle East & Africa Fluidics for Preclinical Market Size by Type
10.2.1 Middle East & Africa Fluidics for Preclinical Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Fluidics for Preclinical Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Fluidics for Preclinical Market Size by Type (2016-2027)
10.3 Middle East & Africa Fluidics for Preclinical Market Size by Application
10.3.1 Middle East & Africa Fluidics for Preclinical Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Fluidics for Preclinical Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Fluidics for Preclinical Market Size by Application (2016-2027)
10.4 Middle East & Africa Fluidics for Preclinical Market Size by Country
10.4.1 Middle East & Africa Fluidics for Preclinical Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Fluidics for Preclinical Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AMETEK Inc
11.1.1 AMETEK Inc Company Details
11.1.2 AMETEK Inc Business Overview
11.1.3 AMETEK Inc Fluidics for Preclinical Introduction
11.1.4 AMETEK Inc Revenue in Fluidics for Preclinical Business (2016-2021)
11.1.5 AMETEK Inc Recent Development
11.2 Blacktrace Holdings Ltd
11.2.1 Blacktrace Holdings Ltd Company Details
11.2.2 Blacktrace Holdings Ltd Business Overview
11.2.3 Blacktrace Holdings Ltd Fluidics for Preclinical Introduction
11.2.4 Blacktrace Holdings Ltd Revenue in Fluidics for Preclinical Business (2016-2021)
11.2.5 Blacktrace Holdings Ltd Recent Development
11.3 Fluigent SA
11.3.1 Fluigent SA Company Details
11.3.2 Fluigent SA Business Overview
11.3.3 Fluigent SA Fluidics for Preclinical Introduction
11.3.4 Fluigent SA Revenue in Fluidics for Preclinical Business (2016-2021)
11.3.5 Fluigent SA Recent Development
11.4 Halma Plc
11.4.1 Halma Plc Company Details
11.4.2 Halma Plc Business Overview
11.4.3 Halma Plc Fluidics for Preclinical Introduction
11.4.4 Halma Plc Revenue in Fluidics for Preclinical Business (2016-2021)
11.4.5 Halma Plc Recent Development
11.5 Harvard Bioscience Inc
11.5.1 Harvard Bioscience Inc Company Details
11.5.2 Harvard Bioscience Inc Business Overview
11.5.3 Harvard Bioscience Inc Fluidics for Preclinical Introduction
11.5.4 Harvard Bioscience Inc Revenue in Fluidics for Preclinical Business (2016-2021)
11.5.5 Harvard Bioscience Inc Recent Development
11.6 IDEX Corp
11.6.1 IDEX Corp Company Details
11.6.2 IDEX Corp Business Overview
11.6.3 IDEX Corp Fluidics for Preclinical Introduction
11.6.4 IDEX Corp Revenue in Fluidics for Preclinical Business (2016-2021)
11.6.5 IDEX Corp Recent Development
11.7 IMI Plc
11.7.1 IMI Plc Company Details
11.7.2 IMI Plc Business Overview
11.7.3 IMI Plc Fluidics for Preclinical Introduction
11.7.4 IMI Plc Revenue in Fluidics for Preclinical Business (2016-2021)
11.7.5 IMI Plc Recent Development
11.8 M Dialysis AB
11.8.1 M Dialysis AB Company Details
11.8.2 M Dialysis AB Business Overview
11.8.3 M Dialysis AB Fluidics for Preclinical Introduction
11.8.4 M Dialysis AB Revenue in Fluidics for Preclinical Business (2016-2021)
11.8.5 M Dialysis AB Recent Development
11.9 Thermo Fisher Scientific Inc
11.9.1 Thermo Fisher Scientific Inc Company Details
11.9.2 Thermo Fisher Scientific Inc Business Overview
11.9.3 Thermo Fisher Scientific Inc Fluidics for Preclinical Introduction
11.9.4 Thermo Fisher Scientific Inc Revenue in Fluidics for Preclinical Business (2016-2021)
11.9.5 Thermo Fisher Scientific Inc Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Fluidics for Preclinical Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Software and Accessories
Table 3. Key Players of Precision Syringe Pumps
Table 4. Global Fluidics for Preclinical Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Fluidics for Preclinical Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Fluidics for Preclinical Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Fluidics for Preclinical Market Share by Regions (2016-2021)
Table 8. Global Fluidics for Preclinical Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Fluidics for Preclinical Market Share by Regions (2022-2027)
Table 10. Fluidics for Preclinical Market Trends
Table 11. Fluidics for Preclinical Market Drivers
Table 12. Fluidics for Preclinical Market Challenges
Table 13. Fluidics for Preclinical Market Restraints
Table 14. Global Fluidics for Preclinical Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Fluidics for Preclinical Market Share by Players (2016-2021)
Table 16. Global Top Fluidics for Preclinical Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fluidics for Preclinical as of 2020)
Table 17. Ranking of Global Top Fluidics for Preclinical Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Fluidics for Preclinical Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Fluidics for Preclinical Product Solution and Service
Table 21. Date of Enter into Fluidics for Preclinical Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Fluidics for Preclinical Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Fluidics for Preclinical Revenue Market Share by Type (2016-2021)
Table 25. Global Fluidics for Preclinical Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Fluidics for Preclinical Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Fluidics for Preclinical Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Fluidics for Preclinical Revenue Market Share by Application (2016-2021)
Table 29. Global Fluidics for Preclinical Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Fluidics for Preclinical Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Fluidics for Preclinical Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Fluidics for Preclinical Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Fluidics for Preclinical Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Fluidics for Preclinical Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Fluidics for Preclinical Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Fluidics for Preclinical Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Fluidics for Preclinical Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Fluidics for Preclinical Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Fluidics for Preclinical Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Fluidics for Preclinical Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Fluidics for Preclinical Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Fluidics for Preclinical Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Fluidics for Preclinical Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Fluidics for Preclinical Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Fluidics for Preclinical Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Fluidics for Preclinical Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Fluidics for Preclinical Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Fluidics for Preclinical Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Fluidics for Preclinical Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Fluidics for Preclinical Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Fluidics for Preclinical Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Fluidics for Preclinical Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Fluidics for Preclinical Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Fluidics for Preclinical Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Fluidics for Preclinical Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Fluidics for Preclinical Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Fluidics for Preclinical Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Fluidics for Preclinical Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Fluidics for Preclinical Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Fluidics for Preclinical Market Size by Country (2022-2027) & (US$ Million)
Table 61. AMETEK Inc Company Details
Table 62. AMETEK Inc Business Overview
Table 63. AMETEK Inc Fluidics for Preclinical Product
Table 64. AMETEK Inc Revenue in Fluidics for Preclinical Business (2016-2021) & (US$ Million)
Table 65. AMETEK Inc Recent Development
Table 66. Blacktrace Holdings Ltd Company Details
Table 67. Blacktrace Holdings Ltd Business Overview
Table 68. Blacktrace Holdings Ltd Fluidics for Preclinical Product
Table 69. Blacktrace Holdings Ltd Revenue in Fluidics for Preclinical Business (2016-2021) & (US$ Million)
Table 70. Blacktrace Holdings Ltd Recent Development
Table 71. Fluigent SA Company Details
Table 72. Fluigent SA Business Overview
Table 73. Fluigent SA Fluidics for Preclinical Product
Table 74. Fluigent SA Revenue in Fluidics for Preclinical Business (2016-2021) & (US$ Million)
Table 75. Fluigent SA Recent Development
Table 76. Halma Plc Company Details
Table 77. Halma Plc Business Overview
Table 78. Halma Plc Fluidics for Preclinical Product
Table 79. Halma Plc Revenue in Fluidics for Preclinical Business (2016-2021) & (US$ Million)
Table 80. Halma Plc Recent Development
Table 81. Harvard Bioscience Inc Company Details
Table 82. Harvard Bioscience Inc Business Overview
Table 83. Harvard Bioscience Inc Fluidics for Preclinical Product
Table 84. Harvard Bioscience Inc Revenue in Fluidics for Preclinical Business (2016-2021) & (US$ Million)
Table 85. Harvard Bioscience Inc Recent Development
Table 86. IDEX Corp Company Details
Table 87. IDEX Corp Business Overview
Table 88. IDEX Corp Fluidics for Preclinical Product
Table 89. IDEX Corp Revenue in Fluidics for Preclinical Business (2016-2021) & (US$ Million)
Table 90. IDEX Corp Recent Development
Table 91. IMI Plc Company Details
Table 92. IMI Plc Business Overview
Table 93. IMI Plc Fluidics for Preclinical Product
Table 94. IMI Plc Revenue in Fluidics for Preclinical Business (2016-2021) & (US$ Million)
Table 95. IMI Plc Recent Development
Table 96. M Dialysis AB Company Details
Table 97. M Dialysis AB Business Overview
Table 98. M Dialysis AB Revenue in Fluidics for Preclinical Business (2016-2021) & (US$ Million)
Table 99. M Dialysis AB Recent Development
Table 100. Thermo Fisher Scientific Inc Company Details
Table 101. Thermo Fisher Scientific Inc Business Overview
Table 102. Thermo Fisher Scientific Inc Fluidics for Preclinical Product
Table 103. Thermo Fisher Scientific Inc Revenue in Fluidics for Preclinical Business (2016-2021) & (US$ Million)
Table 104. Thermo Fisher Scientific Inc Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fluidics for Preclinical Market Share by Type: 2020 VS 2027
Figure 2. Software and Accessories Features
Figure 3. Precision Syringe Pumps Features
Figure 4. Global Fluidics for Preclinical Market Share by Application: 2020 VS 2027
Figure 5. Clinica Case Studies
Figure 6. Research Case Studies
Figure 7. Fluidics for Preclinical Report Years Considered
Figure 8. Global Fluidics for Preclinical Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Fluidics for Preclinical Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Fluidics for Preclinical Market Share by Regions: 2020 VS 2027
Figure 11. Global Fluidics for Preclinical Market Share by Regions (2022-2027)
Figure 12. Global Fluidics for Preclinical Market Share by Players in 2020
Figure 13. Global Top Fluidics for Preclinical Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fluidics for Preclinical as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Fluidics for Preclinical Revenue in 2020
Figure 15. Global Fluidics for Preclinical Revenue Market Share by Type (2016-2021)
Figure 16. Global Fluidics for Preclinical Revenue Market Share by Type (2022-2027)
Figure 17. North America Fluidics for Preclinical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Fluidics for Preclinical Market Share by Type (2016-2027)
Figure 19. North America Fluidics for Preclinical Market Share by Application (2016-2027)
Figure 20. North America Fluidics for Preclinical Market Share by Country (2016-2027)
Figure 21. United States Fluidics for Preclinical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Fluidics for Preclinical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Fluidics for Preclinical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Fluidics for Preclinical Market Share by Type (2016-2027)
Figure 25. Europe Fluidics for Preclinical Market Share by Application (2016-2027)
Figure 26. Europe Fluidics for Preclinical Market Share by Country (2016-2027)
Figure 27. Germany Fluidics for Preclinical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Fluidics for Preclinical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Fluidics for Preclinical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Fluidics for Preclinical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Fluidics for Preclinical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Fluidics for Preclinical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Fluidics for Preclinical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Fluidics for Preclinical Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Fluidics for Preclinical Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Fluidics for Preclinical Market Share by Region (2016-2027)
Figure 37. China Fluidics for Preclinical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Fluidics for Preclinical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Fluidics for Preclinical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Fluidics for Preclinical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Fluidics for Preclinical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Fluidics for Preclinical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Fluidics for Preclinical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Fluidics for Preclinical Market Share by Type (2016-2027)
Figure 45. Latin America Fluidics for Preclinical Market Share by Application (2016-2027)
Figure 46. Latin America Fluidics for Preclinical Market Share by Country (2016-2027)
Figure 47. Mexico Fluidics for Preclinical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Fluidics for Preclinical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Fluidics for Preclinical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Fluidics for Preclinical Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Fluidics for Preclinical Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Fluidics for Preclinical Market Share by Country (2016-2027)
Figure 53. Turkey Fluidics for Preclinical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Fluidics for Preclinical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Fluidics for Preclinical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. AMETEK Inc Revenue Growth Rate in Fluidics for Preclinical Business (2016-2021)
Figure 57. Blacktrace Holdings Ltd Revenue Growth Rate in Fluidics for Preclinical Business (2016-2021)
Figure 58. Fluigent SA Revenue Growth Rate in Fluidics for Preclinical Business (2016-2021)
Figure 59. Halma Plc Revenue Growth Rate in Fluidics for Preclinical Business (2016-2021)
Figure 60. Harvard Bioscience Inc Revenue Growth Rate in Fluidics for Preclinical Business (2016-2021)
Figure 61. IDEX Corp Revenue Growth Rate in Fluidics for Preclinical Business (2016-2021)
Figure 62. IMI Plc Revenue Growth Rate in Fluidics for Preclinical Business (2016-2021)
Figure 63. M Dialysis AB Revenue Growth Rate in Fluidics for Preclinical Business (2016-2021)
Figure 64. Thermo Fisher Scientific Inc Revenue Growth Rate in Fluidics for Preclinical Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed